Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Bower Award and Prize for Achievement in Science

Franklin Institute

The Franklin Institute seeks nominations for the 2026 Bower Award and Prize for Achievement in Science of individuals who have made significant contributions to the development of the field of human gene therapy. Since the concept of gene therapy was proposed more than 50 years ago, the development of therapeutic approaches using directed modification of DNA or cells has made significant progress in tackling challenges of biological complexity. Applications of gene editing systems, novel delivery platforms, and immunotherapies now have the potential to be ‘game-changers’ in the treatment of diseases ranging from in-born errors of metabolism to cancers. Nominations should recognize fundamental contributions to the development of strategies for engineering genetic alterations to cells for the treatment of human disease.

Specialties

Genetics & Genomics

Immunology

Eligibility Requirements

This is an international competition for individuals who have pioneered novel strategies for engineering genetic alterations to cells for the treatment of human disease.
As specified by the will of Henry Bower, this award and prize must be presented to an individual, not to a group.
Candidates must be living, and the winner must participate in The Franklin Institute Awards Week programs, to be held in April 2026 in Philadelphia, Pennsylvania, USA.
Nominations from any individual or organization will be accepted, including self-nominations.
Nominations of candidates traditionally underrepresented in science and engineering are particularly encouraged.

Eligible Countries:

United States

Sponsor Details

Sponsor Institute/Organizations: Franklin Institute

Sponsor Type:

Address: 271 North 21st Street Philadelphia, PA 19103

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity